Gorelick J, Ross D, Marentette L, Blaivas M
Department of Surgery, Section of Neurosurgery, University of Michigan Medical Center, Ann Arbor 48109-0338, USA.
Neurosurgery. 2000 Sep;47(3):750-4; discussion 754-5. doi: 10.1097/00006123-200009000-00045.
We report on four cases of sinonasal undifferentiated carcinoma (SNUC), a relatively newly described clinicopathological entity of the nasal cavity and paranasal sinuses. SNUC tends to present with advanced-stage disease, often with intracranial invasion, and requires an aggressive treatment approach that includes surgical resection. A review of the literature identified several reports of SNUC in pathology and otolaryngology journals since its initial description in 1986, but no report has yet appeared in the neurosurgery literature.
Four patients presented with various symptoms related to the nose and/or orbit, including one or more of the following: obstruction, epistaxis, decreased visual acuity, diplopia, and pain. All patients were noted to have masses in the nasal cavity or paranasal sinuses, with or without intracranial extension.
All four patients underwent multimodal treatment with chemotherapy, radiotherapy (60-65 Gy), and aggressive surgical resection via a combined bifrontal craniotomy and a subcranial approach to the anterior cranial fossa. Three of four patients died as a result of their disease, an average of 15 months after diagnosis. Only one patient remains alive, although with metastatic intracranial disease, at 24 months after diagnosis.
SNUC is a rare neoplasm with a poor prognosis despite an aggressive multimodal approach to treatment. On the basis of our experience, we advocate radical resection as part of the initial combined therapy for patients who present with locally advanced, nonmetastatic disease but we suggest reserving surgery for patients with early brain invasion until there has been a radiographically proven central nervous system response to adjuvant therapy.
我们报告4例鼻窦未分化癌(SNUC),这是一种鼻腔和鼻窦相对较新描述的临床病理实体。SNUC往往表现为晚期疾病,常伴有颅内侵犯,需要积极的治疗方法,包括手术切除。文献回顾发现,自1986年首次描述以来,病理学和耳鼻喉科期刊上有几篇关于SNUC的报道,但神经外科文献中尚未出现相关报道。
4例患者出现与鼻和/或眼眶相关的各种症状,包括以下一种或多种:鼻塞、鼻出血、视力下降、复视和疼痛。所有患者均在鼻腔或鼻窦发现肿物,伴或不伴有颅内扩展。
所有4例患者均接受了多模式治疗,包括化疗、放疗(60 - 65 Gy),并通过双侧额部开颅和经颅下入路至前颅窝进行积极的手术切除。4例患者中有3例因疾病死亡,平均在诊断后15个月。仅1例患者存活,诊断后24个月时伴有颅内转移瘤。
SNUC是一种罕见肿瘤,尽管采用积极的多模式治疗方法,预后仍较差。根据我们的经验,对于局部晚期、无转移的患者,我们主张将根治性切除作为初始联合治疗的一部分,但对于早期脑侵犯的患者,我们建议在影像学证实中枢神经系统对辅助治疗有反应之前保留手术。